The MotivAir Study to Improve CPAP Adherence in OSAS Patients (MotivAir)
Sleep Apnea, Obstructive, Motivational Interviewing
About this trial
This is an interventional treatment trial for Sleep Apnea, Obstructive
Eligibility Criteria
Inclusion Criteria: having a diagnosis of OSAS confirmed by polysomnography; being recommended for treatment with CPAP; being naïve to this type of intervention Exclusion Criteria: use of oxygen therapy > 2 l/min; history of severe cognitive disorders; history of COPD: FEV1/FVC (Tiffeneau Index) ≤ 60% with FEV1 ≤ 50%; dyspnea on exertion (Borg > 6); diagnosis of Long Covid or Covid-19 infection < 4 months; chronic heart failure (NYHA: Grade III and IV); unstable ischemic heart disease; inability to understand the consent to participate; patient refusal.
Sites / Locations
- San Giuseppe Hospital, Istituto Auxologico Italiano IRCSS
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
MotivAir group
Treatment as usual
Subjects in the MotivAir group will follow an intervention - lasting approximately 45 minutes - based on motivational interviewing principles and techniques delivered by a trained nurse.
Participants assigned to the control group will receive a usual pulmonary rehabilitation program for patients with OSAS receiving CPAP therapy, which is a standard technical training comprising information regarding the use, maintenance and safety measures of the device, plus a home inspection delivered by a technician who has the only task of doing maintenance to the machinery.